| Literature DB >> 31882688 |
Jefferson Allan1, Roshan Regmi1, Matthew Denton-Giles1, Lars G Kamphuis1, Mark C Derbyshire2.
Abstract
Sclerotinia sclerotiorum is a necrotrophic fungal pathogen that infects upwards of 400 plant species, including several economically important crops. The molecular processes that underpin broad host range necrotrophy are not fully understood. This study used RNA sequencing to assess whether S. sclerotiorum genes are differentially expressed in response to infection of the two different host crops canola (Brassica napus) and lupin (Lupinus angustifolius). A total of 10,864 of the 11,130 genes in the S. sclerotiorum genome were expressed. Of these, 628 were upregulated in planta relative to in vitro on at least one host, suggesting involvement in the broader infection process. Among these genes were predicted carbohydrate-active enzymes (CAZYmes) and secondary metabolites. A considerably smaller group of 53 genes were differentially expressed between the two plant hosts. Of these host-specific genes, only six were either CAZymes, secondary metabolites or putative effectors. The remaining genes represented a diverse range of functional categories, including several associated with the metabolism and efflux of xenobiotic compounds, such as cytochrome P450s, metal-beta-lactamases, tannases and major facilitator superfamily transporters. These results suggest that S. sclerotiorum may regulate the expression of detoxification-related genes in response to phytotoxins produced by the different host species. To date, this is the first comparative whole transcriptome analysis of S. sclerotiorum during infection of different hosts.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31882688 PMCID: PMC6934579 DOI: 10.1038/s41598-019-56396-w
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Quality control and assignment rates from Trimmomatic and BBSplit.
| Treatment | Replicate | Raw input read pairs | Reads retained by Trimmomatic (%) | Final read pairs | |
|---|---|---|---|---|---|
| 1 | 51,429,980 | 94.9 | NA | 47,609,295 | |
| 2 | 43,993,597 | 94.9 | NA | 40,898,891 | |
| 3 | 42,595,015 | 95.2 | NA | 39,702,901 | |
| 1 | 42,067,707 | 91 | 25.7 | 9,595,914 | |
| 2 | 39,650,442 | 90.7 | 7.5 | 2,630,108 | |
| 3 | 45,312,584 | 92.9 | 44 | 18,079,428 | |
| 1 | 39,982,586 | 92.7 | 26.4 | 9,487,026 | |
| 2 | 40,510,004 | 92.4 | 83.9 | 30,699,672 | |
| 3 | 47,604,827 | 93.9 | 48 | 20,783,466 |
The fifth column refers to the number of in planta S. sclerotiorum reads as a proportion of all in planta reads assigned to the host or pathogen by BBsplit.
Figure 1Proportions of reads mapping to Sclerotinia sclerotiorum and the plant hosts. Replicates C1–3 correspond to B. napus, while replicates L1–3 correspond to L. angustifolius. The y axis shows the percentage of mapped reads and bars are separated into blue (mapping to the plant host genome) and black (mapping to the S. sclerotiorum genome).
Figure 2Scatter plot and heatmap based on principal component analysis conducted in Limma based on gene expression levels. The labels ‘C1’, ‘C2’ and ‘C3’ correspond to the three Brassica napus infected replicates, the labels ‘L1’, ‘L2’ and ‘L3’ correspond to the three Lupinus angustifolius infected replicates, and the labels ‘S1’, ‘S2’ and ‘S3’ correspond to the three Sclerotinia sclerotiorum in vitro replicates. (A) Text is also coloured in red for B. napus, blue for L. angustifolius and green for in vitro samples. The x-axis is principal component 1 and the y-axis is principal component 2. (B) Columns labelled “S” are in vitro replicates, “L” are L. angustifolius and “C” are B. napus. Red regions indicate high gene expression levels, which blue regions indicate low gene expression levels. Replicates are clustered according to the hierarchy at the top of the figure.
Figure 3Scatter plots showing log-fold changes in S. sclerotiorum gene expression against mean log counts-per-million values for all genes. The x-axis shows the mean log CPM of the respective treatments, while the y-axis show the log fold change between the two treatments. Log-fold changes are in planta (L. angustifolius) relative to in vitro (A), in planta (B. napus) relative to in vitro (B), in planta (L. angustifolius) relative to in planta (B. napus) (C).
The top 10 most highly upregulated genes in B. napus and L. angustifolius, ranked from most highly upregulated to least.
| Rank | B. napus | L. angustifolius | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Gene ID | Pfam domain | LFC | Padj | LCPM | Gene ID | Pfam domain | LFC | Padj | LCPM | |
| 1 | sscle_15g106470 | Thioesterase domain | 14.6 | 0.004 | 9.3 | sscle_15g106470 | Thioesterase domain | 14.8 | 0.003 | 9.5 |
| 2 | sscle_05g042570 | NmrA-like family | 13.1 | 0.001 | 10.2 | sscle_11g085620 | Transferase family | 13.8 | 0.03 | 8.6 |
| 3 | sscle_11g085620 | Transferase family | 12.6 | 0.05 | 8.8 | sscle_05g042570 | NmrA-like family | 13.7 | 0.001 | 10.2 |
| 4 | sscle_15g106460 | Transferase family | 12.6 | 0.003 | 8.7 | sscle_15g106460 | Transferase family | 13.2 | 0.002 | 8.7 |
| 5 | sscle_11g085630 | Cytochrome P450 | 11.7 | 0.004 | 9.8 | sscle_07g060710 | FAD binding domain | 13 | 0.023 | 5.7 |
| 6 | sscle_15g106450 | 11.6 | 0.002 | 9 | sscle_11g085630 | Cytochrome P450 | 12.7 | 0.002 | 9.6 | |
| 7 | sscle_08g067130 | Cytochrome P450 | 10.4 | 6.30E-07 | 9.4 | sscle_15g106450 | 12.1 | 0.001 | 9.2 | |
| 8 | sscle_15g106500 | 10.3 | 1.30E-04 | 10.1 | sscle_15g106500 | 10.9 | 8.00E-04 | 10.1 | ||
| 9 | sscle_07g060710 | FAD binding domain | 10 | 0.087 | 8.6 | sscle_08g068200 | Chitin recognition protein | 10.4 | 0.001 | 8.4 |
| 10 | sscle_15g106490 | FAD binding domain | 10 | 0.001 | 8.6 | sscle_02g018820 | Glycosyl hydrolases family 28 | 10.3 | 0.002 | 7.1 |
“LFC” is log-fold change (base 2), “LCPM” is log-counts-per-million in planta (base 2).
All genes significantly differentially expressed by S. sclerotiorum between the in planta treatments.
| Gene ID | Pfam domain | Upreg. in: | Abs. LFC | Padj | ||
|---|---|---|---|---|---|---|
| sscle_05g040340 | Metallo-beta-lactamase | C | 6.8 | 670.1 | 4.6 | 5.10E-06 |
| sscle_05g047240 | Serine hydrolase FSH | C | 3.5 | 63.5 | 9.2 | 5.00E-02 |
| sscle_02g012440 | Major facilitator superfamily | C | 3.9 | 75.6 | 8.3 | 4.40E-03 |
| sscle_05g040320 | Major facilitator superfamily | C | 5.3 | 33.5 | 0.7 | 6.50E-04 |
| sscle_04g037240 | Alcohol dehydrogenase, N-terminal | C | 9 | 159.7 | 0.2 | 1.80E-03 |
| sscle_08g062510 | Methyltransferase type 11 | C | 4 | 1701.5 | 90.6 | 2.70E-04 |
| sscle_01g006290 | Cytochrome P450 | C | 4.1 | 58.1 | 628.4 | 2.50E-04 |
| sscle_03g026490 | NAD-dependent epimerase/dehydratase, N-terminal domain | C | 4.4 | 15.9 | 0.7 | 3.60E-03 |
| sscle_06g048630 | V-ATPase proteolipid subunit C-like domain | L | 2.5 | 14.1 | 47.4 | 2.80E-02 |
| sscle_07g059310 | DSBA-like thioredoxin domain | L | 2.5 | 105.5 | 20.1 | 2.60E-02 |
| sscle_09g073010 | TPMT family | C | 6.3 | 1844.3 | 24.3 | 2.70E-05 |
| sscle_02g021040 | FAD linked oxidase, N-terminal | C | 2.2 | 208.8 | 612.9 | 3.80E-02 |
| sscle_05g047210 | Major facilitator superfamily | C | 3.2 | 169.2 | 23.5 | 3.80E-03 |
| sscle_10g079920 | Carbon-nitrogen hydrolase | L | 4.7 | 12795.5 | 481.1 | 1.00E-04 |
| sscle_10g079370 | Glycoside hydrolase family 3 C-terminal domain | L | 3.4 | 6.3 | 43.1 | 5.30E-03 |
| sscle_04g036270 | Acetoacetate decarboxylase | L | 3.5 | 106 | 709.1 | 1.50E-03 |
| sscle_02g018820 | Glycoside hydrolase, family 28 | C | 7 | 11.2 | 148.3 | 2.90E-03 |
| sscle_03g022380 | NADH:flavin oxidoreductase/NADH oxidase, N-terminal | C | 2.7 | 363.5 | 43.2 | 8.20E-03 |
| sscle_03g026590 | Glycoside hydrolase family 12 | L | 4.6 | 23.1 | 95.3 | 2.30E-02 |
| sscle_05g046770 | GNAT domain | L | 4.5 | 166.6 | 6.1 | 7.60E-04 |
| sscle_16g108230 | Carbon-nitrogen hydrolase | C | 6.7 | 841.3 | 7.3 | 2.00E-06 |
| sscle_05g040330 | Zn(2)-C6 fungal-type DNA-binding domain | L | 5.4 | 62.8 | 1.3 | 1.40E-04 |
| sscle_07g058260 | Short-chain dehydrogenase/reductase SDR | L | 3.5 | 7.5 | 0.8 | 3.20E-02 |
| sscle_08g067140 | Tannase/feruloyl esterase | L | 2 | 25.2 | 101.5 | 3.60E-02 |
| sscle_10g076570 | Tannase/feruloyl esterase | C | 9.1 | 0.7 | 207.5 | 3.80E-03 |
| sscle_10g074860 | FAD-binding domain | C | 2.7 | 39.5 | 7.4 | 3.80E-02 |
| sscle_05g046750 | Hypoxia induced protein, domain | L | 2.2 | 882.8 | 172.1 | 2.50E-03 |
| sscle_01g005000 | Glutathione S-transferase, N-terminal | L | 5.2 | 511.1 | 11.8 | 1.60E-05 |
| sscle_04g033880 | Cytochrome P450 | C | 4.2 | 283 | 3196 | 2.50E-03 |
| sscle_12g089000 | Alpha/beta hydrolase fold-1 | L | 5 | 32.7 | 328.1 | 3.60E-03 |
| sscle_08g067130 | Cytochrome P450 | L | 3.3 | 8287.7 | 636.4 | 2.20E-03 |
| sscle_15g105450 | Pirin, N-terminal domain | C | 3.4 | 134.4 | 18.3 | 3.50E-02 |
| sscle_15g106860 | Isochorismatase-like | L | 4.6 | 8.4 | 0.6 | 2.60E-02 |
| sscle_03g023780 | Carboxylesterase, type B | C | 4.1 | 107.2 | 559 | 4.40E-03 |
| sscle_07g058990 | Glycoside hydrolase family 16 | C | 5.6 | 0.2 | 4.00E-02 | 3.40E-02 |
| sscle_02g022130 | DJ-1/PfpI | L | 9.3 | 1433.9 | 3.3 | 1.30E-04 |
| sscle_05g047220 | Phosphatidylethanolamine-binding protein PEBP | C | 2 | 245.9 | 78.5 | 3.50E-02 |
| sscle_13g092350 | L | 3 | 186 | 23 | 7.90E-06 | |
| sscle_07g059700 | C | 6.1 | 5.9 | 193.7 | 2.60E-04 | |
| sscle_14g098740 | C | 4.9 | 84.8 | 1184.5 | 1.80E-03 | |
| sscle_03g024860 | C | 4.5 | 3.3 | 51.8 | 1.80E-03 | |
| sscle_04g033890 | L | 3.1 | 13.5 | 77.5 | 2.40E-03 | |
| sscle_03g030870 | C | 6.7 | 0.2 | 88.6 | 2.50E-03 | |
| sscle_10g079930 | C | 2.8 | 60.3 | 8.3 | 3.60E-03 | |
| sscle_15g106670 | C | 8.8 | 0 | 55.3 | 3.60E-03 | |
| sscle_13g096350 | C | 2.5 | 6.9 | 41.9 | 4.10E-03 | |
| sscle_08g064180 | C | 2.4 | 237.9 | 52.6 | 7.10E-03 | |
| sscle_05g045300 | C | 3.3 | 63 | 362.4 | 8.60E-03 | |
| sscle_05g047230 | L | 2.1 | 54.7 | 12.5 | 1.70E-02 | |
| sscle_05g042600 | L | 3.4 | 99.8 | 13.7 | 2.60E-02 | |
| sscle_07g061670 | L | 4.7 | 4.4 | 0.3 | 2.80E-02 | |
| sscle_02g022120 | C | 6.8 | 0.3 | 5.40E-03 | 3.50E-02 | |
| sscle_02g013360 | C | 3.2 | 6.8 | 48.9 | 3.80E-02 |
“Abs. LFC” refers to the magnitude of log-fold change in gene expression between the in planta treatments (base 2), “LCPM” refers to the gene expression level in log-counts-per-million (base 2). “L” refers to the L. angustifolius treatment, “C” refers to the B. napus treatment.
Figure 4Scatter plots showing log-fold changes in S. sclerotiorum gene expression against mean log counts-per-million values between the two in planta treatments. The x-axis shows the mean log CPM of the respective treatments, while the y-axis shows the log fold change of gene expression in L. angustifolius relative to B. napus. The gene subsets are predicted secreted CAZymes (A), putative effectors (B), and putative secondary metabolites (C). No secondary metabolites were significantly differentially expressed.
Figure 5Quantitative PCR analysis of selected genes. The results of two experiments are presented. Experiment 1 used the same methodology as the RNA sequencing analysis to generate samples. Experiment 2 used the methodology of Seifbarghi et al. (2017)[13]. The y axis shows the inverse ∆Ct value relative to the housekeeping gene Sclerotinia sclerotiorum β-tubulin. The x axis shows the names of genes included in the analysis. The gene names coloured in green correspond with the RNA sequencing analysis, whereas those in red do not. The thick horizontal black lines represent median values. The boxes and whiskers represent interquartile range and the black points represent outliers. For most of the genes, we were concerned with differential expression between Lupinus angustifolius and Brassica napus, as this was the primary hypothesis we were testing. We also selected the two genes sscle_15g106480 and sscle_15g106510 as they were significantly up-regulated on both B. napus and L. angustifolius relative to in vitro.